ScienceDaily: Health & Medicine News

---

• Eating out = high blood pressure?
• Telomeres and cancer mortality: The long and the short of it
• Breakthrough in cancer research: Cancer-suppressing proteins
• Selenide protects heart muscle in the wake of cardiac arrest
• Call to action for two cancer research fronts to join forces
• Dealing with death in deployment
• Drug resistant mechanism revealed for a new targeted cancer therapy
• Brain imaging explains reason for good, poor language outcomes in ASD toddlers

Eating out = high blood pressure? Posted: 10 Apr 2015 01:53 PM PDT A recent study on university-going young adults is the first ever to show an association between meals eaten away from home and high blood pressure. These findings highlight lifestyle factors that can affect hypertension and emphasize the importance of being aware of the salt and calorie content in food, to facilitate better meal choices when eating out.

Telomeres and cancer mortality: The long and the short of it Posted: 10 Apr 2015 01:53 PM PDT Telomeres are short stretches of repeated nucleotides that protect the ends of chromosomes. In somatic cells, these protective sequences become shorter with each cellular replication until a critical length is reached, which can trigger cell death. At the conclusion of their study, the authors conclude, "We speculate that long telomeres may represent a survival advantage for cancer cells, allowing multiple cell divisions leading to high cancer mortality."

Breakthrough in cancer research: Cancer-suppressing proteins Posted: 10 Apr 2015 06:55 AM PDT Two cancer-suppressing proteins that could hold a key to controlling cancer cell growth and development have been discovered by researchers. The previously undiscovered proteins were found during ongoing research on the ubiquitin system.

Selenide protects heart muscle in the wake of cardiac arrest Posted: 09 Apr 2015 11:31 AM PDT Damage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study.

Call to action for two cancer research fronts to join forces Posted: 09 Apr 2015 10:34 AM PDT Targeting the genetic drivers of cancer works in clinical trials, but cancers often resurface shortly thereafter. Immunotherapy -- which primes a patient's immune cells to attack tumors -- offers a longer-lasting response, but only in a fraction of people. The way forward, argue experts, is to shift funding and research priorities so that these complementary approaches can be combined.

Dealing with death in deployment Posted: 09 Apr 2015 10:32 AM PDT A new study is the first to provide clear insight into contributors to suicide risk among military personnel and veterans who have deployed. The study found that exposure to killing and death while deployed is connected to suicide risk. Previous studies that looked solely at the relationship between deployment and suicide risk without assessing for exposure to killing and death and have shown inconsistent results.

Drug resistant mechanism revealed for a new targeted cancer therapy Posted: 09 Apr 2015 10:32 AM PDT New research shines a light on identifying 'hot spots' in drug-resistant mutations involving a certain protein found to influence cancer growth.

Brain imaging explains reason for good, poor language outcomes in ASD toddlers Posted: 09 Apr 2015 10:32 AM PDT Using functional magnetic resonance imaging (fMRI), researchers say it may be possible to predict future language development outcomes in toddlers with autistic spectrum disorder (ASD), even before they've been formally diagnosed with the condition.

You are subscribed to email updates from Health & Medicine News -- ScienceDaily To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States